Elliplex Inc - Service for Life Sciences
Delivery Affinity Constants and Drug Leads at Low Cost

About Us

Xiangdong Zhu (Ph.D.): Board Director, professor of physics and biophysics with University of California at Davis since 1989. He invented a high-speed optical scanner for label-free detection of biochemical reactions on solid supports (e.g., functionalized glass slides). The scanner is based on a special ellipsometry (see References section). He also developed the fluidic system along with the optical scanner so that they formed a microarray-based binding curve assay platform for protein affinity profiling, protein ligand discovery, and identification of molecular modulators to protein-protein interactions. A highlight of this microarray-based assay platform was featured in the June issue of Assay &Drug Development Technologies in 2012.

Professor Zhu earned the Bachelor Degree of Science in Physics from Peking University in China in 1981, and the Doctoral Degree of Philosophy in Physics from University of California at Berkeley in 1989. He immediately joined the Physics faculty at University of California at Davis. He is an expert in surface sciences and optics, and has extensive working knowledge on biochemical assays on solid supports involving small molecules, macromolecules, viral particles, and whole cells. He is a Fellow of American Physical Society and a Fellow of Optical Society of America.

James P. Landry (Ph.D.): CEO, formerly post-doctoral associate and doctoral student in Professor Zhu's laboratory at UC Davis. He was the chief technical staff person throughout the development and implementation of the high-speed scanner technology and automated fluidics for microarray-based assays.

James Landry earned his Bachelor Degree of Science in Physics from University of California at Davis with the highest honor (the Saxon Prize) bestowed to a physics graduating class in 2000. He received his Doctoral Degree of Philosophy in Physics from University of California at Davis in 2008. His dissertation was on the development of oblique-incidence reflectivity difference scanning microscopes for microarray detection. His graduate and postdoctoral research cover a wide range of aspects of biochemical assays on solid supports.

As the CEO, Dr. Landry is committed to serving customers with needs for cost-effective affinity profiling bio-molecular reagents (ranging from small molecules, proteins, viral particles to whole cells) against known and perspective targets and/or for identifying molecular candidates that modulate specific and non-specific protein-receptor interactions.
 
Xiaowen Guo (Ph.D.): a biochemist who has been working in the field of clinical diagnostics in biotech industry for the last 16 years. Dr. Guo has been with Bio-Rad Laboratories for 11 years, most recently as the R&D Manager of BioPlex2200 Division in Clinical Diagnostics Group. She brings to Elliplex Inc clinical diagnostics expertise and organizational experience.

Xiaowen Guo earned the Bachelor Degree of Science in Biochemistry from Hamline University in Minnesota in 1983. She received her Doctoral Degree of Philosophy in Comparative Biochemistry from University of California at Berkeley in 1989. She worked as a postdoctoral associate on cell cycles at University of California at Davis until 1996. She then joined Helix Diagnostics in 1996 as the Director of Research and Development. Helix Diagnostics was acquired by Bio-Rad in 2001 and Dr. Guo has been with Bio-Rad since.

Web Hosting